Workflow
Microsoft's AI Bet Faces a Major Test This Earnings Season
MarketBeat· 2025-07-24 20:32
Earnings season is underway, so it’s time for investors to focus on some of the top technology stocks. One of the most closely watched names will be Microsoft Corporation NASDAQ: MSFT. The tech giant has delivered a total return of over 16% in the last year and a gain of over 155% in the last five years. Microsoft TodayMSFTMicrosoft$505.87 +0.60 (+0.12%) 52-Week Range$344.79▼$514.64Dividend Yield0.66%P/E Ratio39.09Price Target$548.36Add to WatchlistThe company’s depth and breadth touch the most promising t ...
Nextech3D.ai expands MapD into AI event technology suite
Proactiveinvestors NA· 2025-07-24 20:32
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy
Globenewswire· 2025-07-24 20:31
Agreement with Digital Offering Advances Company's plan to assess innovative treasury-backed financing pathsLA PALMA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer immunotherapies, today announced it has entered into an engagement agreement with Digital Offering LLC, a FINRA- and SEC-registered broker-dealer, to serve as its exclusive placement agent in connection with the company ...
Reborn Coffee Signs $1.3 Million Exclusive China Licensing Agreement with Reborn Health Goods (Shenzhen) Co., Ltd.
Globenewswire· 2025-07-24 20:31
Reborn Coffee Partners with Shenzhen-Based Operator to Lead Multi-Province Expansion in China BREA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Reborn Coffee Inc. (Nasdaq: REBN), a leader in the specialty coffee market, today announced the signing of a $1.3 million exclusive master licensing agreement with Reborn Health Goods (Shenzhen) Co., Ltd., a China-based corporation, granting it full rights to develop and sublicense Reborn Coffee locations throughout mainland China. Under this agreement, Reborn Health ...
Mersana Therapeutics Announces 1-for-25 Reverse Stock Split
Globenewswire· 2025-07-24 20:31
CAMBRIDGE, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will implement a 1-for-25 reverse stock split of the issued shares of the company’s common stock (the Reverse Stock Split), effective at 5:00 p.m. Eastern Time on July 25, 2025. The Reverse Stock Split was approved by the company’s s ...
Vital Farms to Report Second Quarter 2025 Financial Results on August 7, 2025
Globenewswire· 2025-07-24 20:30
AUSTIN, Texas, July 24, 2025 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, will report financial results for the second quarter ended June 29, 2025, on Thursday, August 7, 2025, before market open. Vital Farms will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. To participate on the live call, listeners in North America may dial +1-800-715-9871 and international listeners may d ...
LEEF Brands Announces CAD $1 Million Private Placement
Globenewswire· 2025-07-24 20:30
VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- LEEF Brands, Inc. (CSE: LEEF, OTC: LEEEF) ("LEEF" or the "Company"), a premier California and New York cannabis operator, is pleased to announce a private placement offering (the "Offering") of up to 4,000,000 units of the Company (the “Units”) at a price of C$0.25 per Unit (the "Offering Price"), for gross proceeds of up to C$1,000,000. Each Unit will consist of one common share and one common share purchase warrant (a “Warrant”). Each Warrant ...
For First Time Ever, NBC Sports to Present Kentucky Oaks in Primetime – Friday, May 1, 2026, on NBC and Peacock
Globenewswire· 2025-07-24 20:30
The 152nd Kentucky Derby is Saturday, May 2, 2026, on NBC and PeacockLOUISVILLE, Ky., July 24, 2025 (GLOBE NEWSWIRE) -- NBC Sports will showcase the Kentucky Oaks in primetime for the first time ever in 2026, it was announced today by Churchill Downs Incorporated (Nasdaq: CHDN, “CDI”) and NBC Sports. The 152nd Kentucky Oaks, featuring thoroughbred racing’s best three-year-old fillies, will be presented on Friday, May 1, 2026, at 8 p.m. ET on NBC and Peacock. In addition to premier racing, Kentucky Oaks trad ...
Alpha Modus Holdings Inc. (NASDAQ: AMOD) Eliminates Variable Rate Debt and Finalizes Capital Structure Cleanup
Globenewswire· 2025-07-24 20:30
CHARLOTTE, N.C., July 24, 2025 (GLOBE NEWSWIRE) -- Alpha Modus Holdings Inc. (NASDAQ: AMOD), a pioneer in AI-driven retail technology, is pleased to announce a significant milestone in its ongoing commitment to long-term shareholder value. As of today, the Company confirms that all variable rate debt associated with the DESPAC process has been fully resolved and extinguished. This achievement marks the culmination of a strategic initiative that has been central to Alpha Modus’ financial philosophy over the ...
International Myeloma Society Accepts Telo Genomics' MRD Abstract for Presentation at Its 2025 Meeting
Newsfile· 2025-07-24 20:30
International Myeloma Society Accepts Telo Genomics' MRD Abstract for Presentation at Its 2025 MeetingJuly 24, 2025 8:30 AM EDT | Source: Telo Genomics Corp.Toronto, Ontario--(Newsfile Corp. - July 24, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of telomeres, today announced that the International Myeloma Society ("IMS") has accepted Telo Genomics' abstrac ...